# The American National Red Cross American Red Cross Blood Services Southern Region – FDA Inspection, Jul 22, 2022

Source: https://www.keypedia.com/records/fda_inspections/the-american-national-red-cross-american-red-cross-blood-services-southern-region/9fc8ff30-85be-454e-90c6-09b71d3e6c28
Source feed: FDA_Inspections

> FDA inspection 1176915 of The American National Red Cross American Red Cross Blood Services Southern Region, July 22, 2022. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1176915
- Company Name: The American National Red Cross American Red Cross Blood Services Southern Region
- Inspection Date: 2022-07-22
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1290058 - 2025-10-27
- [FDA Inspection 1036764 - 2017-12-15](https://www.keypedia.com/records/fda_inspections/the-american-national-red-cross-american-red-cross-blood-services-southern-region/bde5e390-9fb6-4f44-b9d8-631da11bed90)
- FDA Inspection 966626 - 2016-04-21
- FDA Inspection 863008 - 2014-01-24
- FDA Inspection 753859 - 2011-11-18

Company: https://www.keypedia.com/companies/the-american-national-red-cross-american-red-cross-blood-services-southern-region/1a38d861-4af5-415e-95de-0ba56bc784d4

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d